SEBELA PHARMACEUTICALS RXDIRECT

LIVE

Serial Number

88052552

Owner

SEBELA IRELAND LIMITED

Attorney

Jeffrey H. Handelsman

First Use Date

Feb 2, 2018

Filing Date

Jul 25, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SEBELA PHARMACEUTICALS RXDIRECT Trademark

Serial Number: 88052552 • Registration: 5985373

SEBELA PHARMACEUTICALS RXDIRECT is a trademark filed by SEBELA IRELAND LIMITED on July 25, 2018. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Trademark Classes

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

SEBELA IRELAND LIMITED (31 trademarks)

ADELAIDE CHAMBERS, PETER STREET
DUBLIN 8 , IE

Entity Type: 11

SEBELA INTERNATIONAL BERMUDA LIMITED (30 trademarks)

H.P. HOUSE, 21 LAFFAN STREET
HAMILTON HM 09 , BM

Entity Type: 11

Legal Representation

Attorney of Record

Jeffrey H. Handelsman

2,685 trademarks filed View all →

Correspondence Address

JEFFREY H. HANDELSMAN GREENBLUM & BERNSTEIN, P.L.C.

1950 ROLAND CLARKE PLACE

RESTON, VA 20191-1411

UNITED STATES

Trademark Details

Filing Date

July 25, 2018

Registration Date

February 11, 2020

First Use Anywhere

February 2, 2018

First Use in Commerce

February 2, 2018

Published for Opposition

February 5, 2019

Goods & Services

Mail order pharmacy services; Mail order services featuring prescription drug products or services and medical supplies; Order fulfillment of pharmaceuticals; Order fulfillment services, namely, monitoring and tracking the order status of prescription drugs, drug therapy, prescription refills; Order fulfillment and home delivery services featuring prescription drug products or services and medical supplies; Business administration of patient reimbursement programs

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 11, 2025 REM1

REGISTERED-PRINCIPAL REGISTER

Feb 11, 2020 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 10, 2020 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 9, 2020 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Dec 4, 2019 SUPC

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 8, 2019 EXRA

SOU EXTENSION 1 GRANTED

Oct 7, 2019 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 7, 2019 AITU

USE AMENDMENT FILED

Oct 2, 2019 IUAF

SOU EXTENSION 1 FILED

Oct 2, 2019 EXT1

SOU TEAS EXTENSION RECEIVED

Oct 2, 2019 EEXT

TEAS STATEMENT OF USE RECEIVED

Oct 2, 2019 EISU

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jul 24, 2019 ASGN

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 2, 2019 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 5, 2019 NPUB

PUBLISHED FOR OPPOSITION

Feb 5, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 16, 2019 NONP

ASSIGNED TO LIE

Dec 31, 2018 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 11, 2018 CNSA

EXAMINER'S AMENDMENT ENTERED

Nov 28, 2018 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 28, 2018 GNEN

EXAMINERS AMENDMENT E-MAILED

Nov 28, 2018 GNEA

EXAMINERS AMENDMENT -WRITTEN

Nov 28, 2018 CNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 18, 2018 GNRN

NON-FINAL ACTION E-MAILED

Nov 18, 2018 GNRT

NON-FINAL ACTION WRITTEN

Nov 18, 2018 CNRT

ASSIGNED TO EXAMINER

Nov 13, 2018 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 30, 2018 NWOS

NEW APPLICATION ENTERED

Jul 28, 2018 NWAP

Related Trademarks

More from this Owner

SEBELA PHARMA RX DIRECT

More in Same Class

COMMUNICATING THRU EYE CARE

EARTH WARRIOR ESSENTIALS

PCG PREFERRED CONSULTING GROUP

GARZ FRICKE

MAKE THE DEAL NOW

MISSION